These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7517673)
1. Antisense src expression inhibits proliferation and erythropoietin-induced erythroid differentiation of K562 human leukemia cells. Kitanaka A; Waki M; Kamano H; Tanaka T; Kubota Y; Ohnishi H; Takahara J; Irino S Biochem Biophys Res Commun; 1994 Jun; 201(3):1534-40. PubMed ID: 7517673 [TBL] [Abstract][Full Text] [Related]
2. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells. Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628 [TBL] [Abstract][Full Text] [Related]
3. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, inhibits erythropoietin-induced erythroid differentiation of K562 cells. Kubota Y; Tanaka T; Yamaoka G; Yamaguchi M; Ohnishi H; Kawanishi K; Takahara J; Irino S Leukemia; 1996 Apr; 10(4):720-6. PubMed ID: 8618453 [TBL] [Abstract][Full Text] [Related]
4. Antisense src expression inhibits U937 human leukemia cell proliferation in conjunction with reduction of c-myb expression. Waki M; Kitanaka A; Kamano H; Tanaka T; Kubota Y; Ohnishi H; Takahara J; Irino S Biochem Biophys Res Commun; 1994 Jun; 201(2):1001-7. PubMed ID: 7516155 [TBL] [Abstract][Full Text] [Related]
5. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation. Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946 [TBL] [Abstract][Full Text] [Related]
6. Control of hemoglobin synthesis in erythroid differentiating K562 cells. I. Role of iron in erythroid cell heme synthesis. Kawasaki N; Morimoto K; Tanimoto T; Hayakawa T Arch Biochem Biophys; 1996 Apr; 328(2):289-94. PubMed ID: 8645006 [TBL] [Abstract][Full Text] [Related]
7. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation. Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023 [TBL] [Abstract][Full Text] [Related]
8. Regulation of pp60c-src expression in rat and mouse fibroblasts by an inducible antisense gene: effects on serum regulation of growth and polyoma virus middle T function. Talmage DA; Riney C; Benjamin TL Cell Growth Differ; 1991 Jan; 2(1):51-8. PubMed ID: 1706618 [TBL] [Abstract][Full Text] [Related]
9. Erythroid differentiation and the cell cycle: some implications from murine foetal and erythroleukemic cells. Rifkind RA; Marks PA; Bank A; Terada M; Maniatis GM; Reuben R; Fibach E Ann Immunol (Paris); 1976; 127(6):887-93. PubMed ID: 1070288 [TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation. Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401 [TBL] [Abstract][Full Text] [Related]
11. Physician Education: The Erythropoietin Receptor and Signal Transduction. Yoshimura A; Arai K Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012 [TBL] [Abstract][Full Text] [Related]
12. An increase in the expression and total activity of endogenous p60(c-Src) in several factor-independent mutants of a human GM-CSF-dependent leukemia cell line (TF-1). Horn S; Meyer J; Stocking C; Ostertag W; Jücker M Oncogene; 2003 Oct; 22(46):7170-80. PubMed ID: 14562045 [TBL] [Abstract][Full Text] [Related]
13. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs. Gewirtz DA; Di X; Walker TD; Sawyer ST Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039 [TBL] [Abstract][Full Text] [Related]
14. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells. Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861 [TBL] [Abstract][Full Text] [Related]
16. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles. Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248 [TBL] [Abstract][Full Text] [Related]
17. A multifunctional 5-aminolevulinic acid derivative induces erythroid differentiation of K562 human erythroleukemic cells. Berkovitch-Luria G; Yakobovitch S; Weitman M; Nudelman A; Rozic G; Rephaeli A; Malik Z Eur J Pharm Sci; 2012 Aug; 47(1):206-14. PubMed ID: 22705251 [TBL] [Abstract][Full Text] [Related]
18. Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model. Wiener JR; Nakano K; Kruzelock RP; Bucana CD; Bast RC; Gallick GE Clin Cancer Res; 1999 Aug; 5(8):2164-70. PubMed ID: 10473101 [TBL] [Abstract][Full Text] [Related]
19. In vitro proliferation and differentiation of erythroid progenitors of cord blood. Sakatoku H; Inoue S Stem Cells; 1997; 15(4):268-74. PubMed ID: 9253110 [TBL] [Abstract][Full Text] [Related]
20. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin. Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]